Article
Monitoring of cancer patients via next‐generation sequencing of patient‐derived circulating tumor cells and tumor DNA
6 Jun 2019
Abstract excerpt
Liquid biopsy of circulating tumor cells (CTC) and circulating tumor DNA (ctDNA) is gaining attention as a method for real-time monitoring in cancer patients. Conventional methods based upon epithelial cell adhesion molecule (EpCAM) expression have a risk of missing the most aggressive CTC subpopulations due to epithelial-mesenchymal transition and may, thus, underestimate the total number of actual CTC present...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
